<DOC>
	<DOCNO>NCT01949857</DOCNO>
	<brief_summary>The purpose Phase 4 trial ass safety , immunogenicity , three-year immune persistence inactivate hepatitis A vaccine ( HAV ) live attenuate HAV vaccine .</brief_summary>
	<brief_title>The Immunogenicity Safety Inactivated Live Attenuated Hepatitis A Vaccines</brief_title>
	<detailed_description>Hepatitis A refers liver inflammation cause infection hepatitis A virus . HAV one common hepatitis virus cause hepatitis China . The data phase 1 , 2 3 trial suggest inactivated hepatitis A vaccine live attenuate hepatitis A vaccine clinically acceptable safety good immunogenicity healthy Chinese people .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Only subject fulfil follow criterion eligible study : People age 18 month 65 year old . The subject subject ' guardian able understand sign inform consent The subject subject ' guardian allow comply requirement protocol Subjects temperature &lt; =37.0°C axillary set The subject sign informed consent already Subjects eligible study follow criterion meet : Subject medical history serious disease include Tumor , autoimmune disease , progressive atherosclerosis disease complication diabetes , chronic obstructive pulmonary disease ( copd ) , kidney disease , congestive heart failure etc . Have history neurological symptom sign Have medical history family history relate allergy , seizure , epilepsy , brain spirit etc . Suffering serious chronic disease Suffering know suspected disease include respiratory disease , acute infection , mother HIV infection , cardiovascular disease , severe hypertension , skin disease , malignant tumor Allergic ingredient research , history allergy vaccination ( always ) , especially people allergic high protein food like egg milk Any prior know suspected damage abnormal immune function . As patient treat immune inhibitor immune enhancer medicine , accept immunoglobin , blood product plasma extraction within 3 month Any prior disease include human immunodeficiency virus infection relate Bleeding constitution prolong bleeding time situation Accept hepatitis A vaccination within month Received vaccine , immune globulin , research drug injection past 4 week People acute illness , need systemic antibiotic antiviral treatment past 7 day Caught fever axillary temperature 38°C high past 3 day Take part another clinical researcher Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent Pregnancy test result positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Hepatitis A</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Safety</keyword>
	<keyword>efficacy</keyword>
</DOC>